Please wait while the formulary information is being retrieved.
TERBUTALINE SULFATE (TERBUTALINE SULFATE)
- Acute asthma attack
- Asthma
- Chronic obstructive pulmonary disease with bronchospasms
- Pulmonary emphysema
terbutaline 1 mg/mL subcutaneous solution
- Dosage information is not available
1 mg/mL subcutaneous solution
- Dosage information is not available
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- None
- Compression of umbilical cord
- Myocardial ischemia
- Placental abruption
Contraindicated
- Cardiac arrhythmia
- Chronic myocardial ischemia
- Hypertension
- Hypokalemia
- Pulmonary edema
Severe
Moderate
- Diabetes mellitus
- Hyperthyroidism
- Ketoacidosis
- Seizure disorder
TERBUTALINE SULFATE (TERBUTALINE SULFATE)
- Acute asthma attack
- Asthma
- Chronic obstructive pulmonary disease with bronchospasms
- Pulmonary emphysema
- None
- Nervousness
- Tremor
More Frequent
Severe
Less Severe
- None
- Cramps
- Dizziness
- Drowsy
- General weakness
- Hyperhidrosis
- Insomnia
- Nausea
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute myocardial infarction
- Cardiac arrhythmia
- Chest pain
- Hyperglycemia
- Hypertension
- Hypokalemia
- Myocardial ischemia
- Paradoxical bronchospasm
- Pulmonary edema
- Tachycardia
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Terbutaline (Oral,Inj)
Insufficient clinical data to support safety and efficacy. Not recommended by manufacturer.
- 1 Day – 12 Years
- Insufficient clinical data to support safety and efficacy. Not recommended by manufacturer.
Terbutaline (inj)
- Severity Level:
C
- Additional Notes: Assess risk/benefit for preterm labor; prolonged use >48 to 72 hours not rec
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Terbutaline
No adverse effects observed. long term effects not studied.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | No adverse effects observed. long term effects not studied. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Terbutaline should not be used for more than 2-3 days when treating early labor. Using terbutaline for prevention or prolonged treatment (greater than 2-3 days) of early labor has risks to the mother that are greater than any possible benefits. Serious (sometimes fatal) side effects have rarely occurred in mothers using terbutaline during labor, such as chest pain, fast/irregular heartbeats, and trouble breathing.<br /><br />Tell your doctor right away should any of these side effects occur. If you are pregnant or become pregnant and are using terbutaline for another medical condition (such as asthma), talk to your doctor or pharmacist about whether terbutaline is still right for you.
| Acute asthma attack | |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J98.01 | Acute bronchospasm |
| Asthma | |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.99 | Other asthma |
| J45.990 | Exercise induced bronchospasm |
| J45.991 | Cough variant asthma |
| J45.998 | Other asthma |
| Chronic obstructive pulmonary disease with bronchospasms | |
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Pulmonary emphysema | |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| 0-9 | A-Z |
|---|---|
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.21 | Mild intermittent asthma with (acute) exacerbation |
| J45.22 | Mild intermittent asthma with status asthmaticus |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.31 | Mild persistent asthma with (acute) exacerbation |
| J45.32 | Mild persistent asthma with status asthmaticus |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.41 | Moderate persistent asthma with (acute) exacerbation |
| J45.42 | Moderate persistent asthma with status asthmaticus |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.51 | Severe persistent asthma with (acute) exacerbation |
| J45.52 | Severe persistent asthma with status asthmaticus |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.901 | Unspecified asthma with (acute) exacerbation |
| J45.902 | Unspecified asthma with status asthmaticus |
| J45.909 | Unspecified asthma, uncomplicated |
| J45.99 | Other asthma |
| J45.990 | Exercise induced bronchospasm |
| J45.991 | Cough variant asthma |
| J45.998 | Other asthma |
| J98.01 | Acute bronchospasm |
Formulary Reference Tool